Aisel Raises €1.7M to Tackle Psychiatry's Capacity Crisis

A Danish HealthTech company, Aisel Health, has announced the closure of a €1.7 million pre-seed round to tackle the capacity crisis in psychiatry. The funding round was led by Caesar Ventures, with participation from Nordic Web Ventures, LifeX, Angel Invest, Rockstart, and EIFO.

The capacity crisis in psychiatry is a pressing issue, with patients often waiting weeks, months, or even longer to see a clinician. This is due to a combination of factors, including underfunding, stigma, and a lack of innovation in the field.

Aisel's Operating System (OS) is designed to address this issue by providing clinicians with the information they need to make informed decisions. The platform uses AI scribes to capture context and surface relevant information, reducing the burden on clinicians and improving patient outcomes.

According to Christian Houen, Aisel's co-founder and Chief Product Officer, the current approach to documentation is not sufficient. "AI scribes work - they write notes faster, and that's great for immediate burnout," he said. "But that's not what's keeping waiting lists long. Make notes cheaper to produce, and you just make that information harder for a clinician to find when they need it."

Aisel's platform aims to change this by providing clinicians with concise, organised information shortly before a consultation. This enables them to arrive prepared without adding more prep time, while reducing both consultation and post-appointment documentation time.

## Reducing the Burden on Clinicians

Aisel's research, "The Documentation Minute", found that psychiatrists spend far more time on evidence gathering than on writing the note itself. Clinicians spend only around 40 per cent of their time with patients, with the rest spent on documentation, reading, gathering information, and writing.

Aisel's platform aims to reduce this burden by turning interview recordings, existing documents, and patients' own accounts into structured, contextual insights. This enables clinicians to focus on what matters most - providing high-quality care to their patients.

## Maintaining Continuity of Care

Aisel's platform also helps clinicians maintain continuity of care by surfacing the information most relevant to the clinician at a particular point in a patient's treatment. This is achieved through a "sphere of understanding" that develops over time as more information is gathered.

Rather than searching through multiple documents to work out what matters, clinicians are presented with the relevant information directly, along with its sources and citations. This enables them to make informed decisions and provide high-quality care to their patients.

## Expanding Intake Technology

Aisel has expanded its intake technology beyond the work it did last year. In the case of the ADHD diagnostic process, for example, Aisel can send AI interviews to a patient's relatives, as well as to schools and other relevant parties, so they're all contributing to the same shared understanding of the patient.

This is particularly relevant in child and youth psychiatry, where information from multiple sources is essential for accurate diagnosis and treatment. Aisel's technology can help streamline this process, reducing the time and effort required to gather information.

## Smoothing Clinic Operations

Aisel is also committed to smoothing the entire operational process within clinics. Understanding the patient and gathering information is the first step, but many activities are happening around the patient - rebooking appointments, managing medications, ordering prescriptions, and other administrative tasks.

Aisel's platform aims to own more of this collaboration between clinicians working around the same patient. This will help reduce waiting times and improve patient outcomes.

The funding will be used to grow Aisel's clinical and engineering team and fund its UK market entry, converting an active commercial pipeline of private psychiatry, ahead of a planned seed round. The goal is to give clinicians everything that matters about a patient, exactly when they need it, and in doing so, help shorten the waiting lists that have defined psychiatric care for too long.

| Investor | Participation | | --- | --- | | Caesar Ventures | Lead investor | | Nordic Web Ventures | Participating investor | | LifeX | Participating investor | | Angel Invest | Participating investor | | Rockstart | Participating investor | | EIFO | Participating investor |

The new funding will support Aisel's mission to address the capacity crisis in psychiatry and provide clinicians with the tools they need to deliver high-quality care to their patients.